Status | Study |
Active, not recruiting |
Study Name: A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease Condition: Multicentric Castleman's Disease Date: 2009-11-30 Interventions: Drug: Siltuximab Siltuximab 11 |
Completed |
Study Name: Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials Condition: Aids-related Malignancies Lymphoma Precancerous Condition Date: 2008-06-07 Interventions: Genetic: polymerase chain reaction |
Withdrawn |
Study Name: Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease Condition: Giant Lymph Node Hyperplasia Date: 2006-08-08 Interventions: Drug: Valganciclovir valganciclovir open label, two 450mg tablets orally, twice a day |
Completed |
Study Name: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis Condition: Chronic Myeloproliferative Disorders Leukemia Lymphoma Date: 2005-08-16 Interventions: Drug: tanespimycin |
Terminated |
Study Name: Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy Condition: HIV Infections Giant Lymph Node Hyperplasia Date: 2005-08-04 Interventions: Drug: Rituximab |
Recruiting |
Study Name: Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity Condition: Lymphoproliferative Disorder HHV-8 Malignancy Date: 2004-09-21 Interventions: Drug: Etoposide Etoposide 50 m |
Recruiting |
Study Name: Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer Condition: HIV Kaposi's Sarcoma Lymphomas Date: 2000-11-22 |